↓ Skip to main content

Cochrane Database of Systematic Reviews

Serenoa repensfor benign prostatic hyperplasia

Overview of attention for article published in Cochrane database of systematic reviews, December 2012
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (98th percentile)
  • High Attention Score compared to outputs of the same age and source (92nd percentile)

Citations

dimensions_citation
118 Dimensions

Readers on

mendeley
322 Mendeley
Title
Serenoa repensfor benign prostatic hyperplasia
Published in
Cochrane database of systematic reviews, December 2012
DOI 10.1002/14651858.cd001423.pub3
Pubmed ID
Authors

James Tacklind, Roderick MacDonald, Indy Rutks, Judith U Stanke, Timothy J Wilt

Abstract

Benign prostatic hyperplasia (BPH) is a nonmalignant enlargement of the prostate, which can lead to obstructive and irritative lower urinary tract symptoms (LUTS). The pharmacologic use of plants and herbs (phytotherapy) for the treatment of LUTS associated with BPH is common. The extract of the berry of the American saw palmetto, or dwarf palm plant, Serenoa repens (SR), which is also known by its botanical name of Sabal serrulatum, is one of several phytotherapeutic agents available for the treatment of BPH.

Twitter Demographics

The data shown below were collected from the profiles of 19 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 322 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Germany 2 <1%
Italy 2 <1%
Australia 1 <1%
Brazil 1 <1%
Belgium 1 <1%
Unknown 315 98%

Demographic breakdown

Readers by professional status Count As %
Student > Master 57 18%
Student > Bachelor 51 16%
Researcher 36 11%
Other 26 8%
Student > Postgraduate 22 7%
Other 74 23%
Unknown 56 17%
Readers by discipline Count As %
Medicine and Dentistry 142 44%
Nursing and Health Professions 24 7%
Pharmacology, Toxicology and Pharmaceutical Science 22 7%
Agricultural and Biological Sciences 18 6%
Biochemistry, Genetics and Molecular Biology 12 4%
Other 39 12%
Unknown 65 20%

Attention Score in Context

This research output has an Altmetric Attention Score of 80. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 22 July 2021.
All research outputs
#425,940
of 21,993,335 outputs
Outputs from Cochrane database of systematic reviews
#804
of 12,161 outputs
Outputs of similar age
#3,631
of 294,186 outputs
Outputs of similar age from Cochrane database of systematic reviews
#35
of 458 outputs
Altmetric has tracked 21,993,335 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 98th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 12,161 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 29.8. This one has done particularly well, scoring higher than 93% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 294,186 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 98% of its contemporaries.
We're also able to compare this research output to 458 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 92% of its contemporaries.